Quarry LP Invests $28,000 in Addus HomeCare Co. (NASDAQ:ADUS)

Quarry LP bought a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 214 shares of the company’s stock, valued at approximately $28,000.

Several other institutional investors have also bought and sold shares of ADUS. UMB Bank n.a. increased its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the last quarter. Quest Partners LLC purchased a new position in Addus HomeCare in the second quarter worth $31,000. Farther Finance Advisors LLC grew its stake in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. Innealta Capital LLC purchased a new stake in shares of Addus HomeCare during the 2nd quarter valued at $44,000. Finally, Sandia Investment Management LP bought a new stake in shares of Addus HomeCare during the 2nd quarter worth $58,000. Institutional investors own 95.35% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Up 0.9 %

Shares of NASDAQ ADUS opened at $122.00 on Friday. The company has a market cap of $2.21 billion, a P/E ratio of 27.92, a P/E/G ratio of 2.11 and a beta of 1.01. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The business has a 50-day simple moving average of $125.67 and a two-hundred day simple moving average of $124.28.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the previous year, the company earned $1.03 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. Equities research analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. KeyCorp initiated coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.